SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-22-003926
Filing Date
2022-02-22
Accepted
2022-02-22 08:03:54
Documents
16
Period of Report
2022-02-21
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K snbp20220218_8k.htm   iXBRL 8-K 54483
2 EXHIBIT 2.1 ex_338175.htm EX-2.1 944692
3 EXHIBIT 99.1 ex_338673.htm EX-99.1 24409
8 ex_338673img001.gif GRAPHIC 4927
  Complete submission text file 0001437749-22-003926.txt   1372555

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA pbla-20220221.xsd EX-101.SCH 3601
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pbla-20220221_def.xml EX-101.DEF 11532
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE pbla-20220221_lab.xml EX-101.LAB 15414
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pbla-20220221_pre.xml EX-101.PRE 11688
10 EXTRACTED XBRL INSTANCE DOCUMENT snbp20220218_8k_htm.xml XML 2552
Mailing Address 712 VISTA BLVD #305 WACONIA MN 55387
Business Address 712 VISTA BLVD #305 WACONIA MN 55387 9524791196
Panbela Therapeutics, Inc. (Filer) CIK: 0001029125 (see all company filings)

IRS No.: 870543922 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39468 | Film No.: 22655080
SIC: 2834 Pharmaceutical Preparations